1 / 75

Evaluation of Cardiac Masses

Anne-Marie Anagnostopoulos, MD Non-Invasive Conference April 8, 2009. Evaluation of Cardiac Masses. Outline. Clinical Presentation Echocardiographic Evaluation and Normal Variants Primary Cardiac Tumors Metastatic Disease in the Heart Cardiac Thrombus Summary. Presentation.

Download Presentation

Evaluation of Cardiac Masses

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anne-Marie Anagnostopoulos, MD Non-Invasive Conference April 8, 2009 Evaluation of Cardiac Masses

  2. Outline • Clinical Presentation • Echocardiographic Evaluation and Normal Variants • Primary Cardiac Tumors • Metastatic Disease in the Heart • Cardiac Thrombus • Summary

  3. Presentation • Cardiac tumors are often misdiagnosed because they are rare • Examples of confusion include: RHD, endocarditis, myocarditis, pulmonary embolism, PHTN, vasculitis • Can present with heart failure, arrhythmia, or embolic phenomena

  4. Presentation • Heart Failure: Due to obstruction of outflow tract or cavity filling or dysfunction due to myocardial involvement • Arrythmias: More often occur with intramural involvement; SVT’s with atrial masses, PVC/VT/VF with ventricular myocardial involvement and conduction problems with AV node involvement • Emboli: Right and left sided phenomena

  5. Normal Variants on Echo • Many benign findings on echo often misinterpreted as pathologic • Chiari network, Eustatian valve, Catheters, crista terminalis • Suture line, coronary sinus, moderator band, muscle bundles • False chords, trabeculations, Brachiocephalic vein, pleural effusion • Other non-cardiac findings

  6. Eustatian Valve

  7. Chiari Network

  8. Primary Cardiac Tumors • The vast majority are benign – 75% • In an autopsy series, incidence was only found to be 0.02 % • TTE can identify masses/tumors accurately and is useful in follow up • CT can define myocardial infiltration, calcification and surrounding structures • Cardiac MRI offers the best soft tissue characterization and correlates well with pathological findings • T1 images good for soft tissue, T2 for tissue contrast and fluid components (useful for heterogeneous masses) • Can suppress fat signals (useful for lipomas) • Gadolinium enhancement can define myocardial infiltration, vascularity of mass, and differentiate between mass and thrombus

  9. Benign Primary Cardiac Tumors Braunwald’s, 7th Edition, page 1746

  10. Cardiac Myxomas • 75% are found in Left Atrium • Site of attachment almost always the limbus of the fossa ovalis • 15-20% in the right atrium, less often in right and left ventricles • 90% are solitary, average size 5-6cm (range 1-15 cm) • Average age of presentation is 50 years old

  11. Cardiac Myxomas – Echo Features • Mobile Tumor • Narrow Stalk connected to fossa ovalis • Heterogenous with hypo/hyper-echoic foci • Lucent areas and areas of calcification • If appearance is typical, TTE is diagnostic • TEE and 3D echo can supplement characterization of myxomas

  12. Cardiac Myxoma - TTE

  13. Cardiac Myxoma - TEE

  14. Cardiac Myxoma- 3D echo

  15. Cardiac Myxoma

  16. Cardiac Myxomas – CT and MRI Features • Contrast enhanced CT: usually demonstrates well defined mass with lobular contours that does not enhance • CMR findings of Heterogeneous mass with heterogeneous enhancement • Primarily isointense on T1, and hyperintense on T2 images

  17. Cardiac Myxomas - Treatment • Treatment is surgical with en bloc resection including rim of septum around base • Recurrence in about 1-5% of cases (incomplete resection, implantation from first tumor etc) - therefore annual surveillance recommended • In the familial Carney complex (combination of myxomas, pigmented skin lesions, and endocrine neoplasia)– risk of recurrence 12-22%

  18. Cardiac Myxomas

  19. Papillary Fibroelastomas • Benign papilloma of endocardium • Average age of detection is 60 years old • Found equally in men and women • Many are clinically silent but can result in emboli

  20. Papillary Fibroelastoma – Echo Features • 90% are single, with median diameter of 8mm • Most commonly found on downstream side of valves (can be confused for vegetations) • Less common locations: Papillary muscle, chordae tendenae or atria • Irregularly shaped with delicate frond-like surface • Mobility is common and risk factor for embolization • Valvular regurgitation is rare • Controversial if they are distinct from Lambl’s excrescences (acellular deposits covered by endothelium on valves, often at closure margins) • Because of small size – difficult to see on CT or MRI

  21. Papillary Fibroelastoma – TTE

  22. Papillary Fibroelastoma - TEE

  23. ? MRI PF CMR same patient

  24. CMR same patient

  25. Papillary Fibroelastoma – Less Common Site

  26. Papillary Fibroelastoma –Treatment • Most recommend resection, especially for left sided lesions • Risk of embolism can be up to 25% over 3 years and 6% in asymptomatic patients in whom the fibroelastoma was found incidentally • Surgery can usually be valve-sparing • Recurrences have not been reported

  27. Papillary Fibroelastoma

  28. Cardiac Lipomas • Uncommon benign tumor, usually small and found on epicardial surface • True lipomas are rare, more often present as lipomatous hypertrophy of the interatrial septum • Highly echogenic • Usually present in inferior and superior portions of the septum with sparing of fossa ovalis  “dumbell-shaped” • Associated with atrial arrhythmias • No enhacement on MRI, decreased signal with fat suppression • True lipomas  resection • Lipomatous hypertrophy  surgery only if SVC obstructed or significant arrhythmias

  29. Cardiac Lipoma – CMR Imaging After fat suppression turned on:

  30. Lipomatous Hypertrophy of Interatrial Septum

  31. Lipomatous Hypertrophy of Interatrial Septum

  32. Rhabdomyomas and Fibromas • Most common cardiac tumor in children • Rhabdomyomas occur within a cavity or embedded within myocardium, usual small and multiple; often regress on own • Fibromas are well-demarcated, echogenic masses that can extend into cavity and result in obstruction and arrhythmia; often found in free wall of LV • On MRI rhabomyomas are hyperintense on T2, while fibromas are hypointense on T2 and iso-intense after gadolinium

  33. Rhabdomyomas and Fibromas

  34. Cardiac Fibroma

  35. Malignant Primary Cardiac Tumors Braunwald’s, 7th Edition, page 1746

  36. Malignant Primary Cardiac Tumors – Echo Assessment • Much less common than metastatic disease • Malignant tumors tend to invade/replace myocardial tissue with disruption of normal anatomy • Heart can appear teathered • Associated pericardial effusion is common • Angiosarcoma often involves right atrium • Rhabdomyosarcoma can occur anywhere

  37. Cardiac Angiosarcoma • No consensus on treatment • Surgery, chemotherapy and radiation have been used • Prognosis is poor – survival about 1 year after diagnosis

  38. Malignant Cardiac Tumors – CT and MRI assessment • Angiosarcoma on CT: low attenuation, irregular or nodular with contrast enhacement • Angiosarcoma on MRI: heterogeneous signal intensity on T2 images due to blood filled spaces in neoplasm; heterogeneous enhancement with gadolinium; late enhancement due to fibrosis

  39. Angiosarcoma on MRI T2 weighted image

  40. Primary Cardiac Lymphoma • Rare, especially in immunocompetent patients • Median age of presentation is 64 years old, 3:1 male:female • Often aggressive B-cell lymphomas associated with EBV • Typically present with right sided heart failure, fever, arrhythmias, tamponade • Most commonly arises from Right atrium and half have pericardial effusions (often large) • TTE only moderate sensitivity, MRI has best sensitivity; biopsy is diagnostic • Survival approximately 1 year, with chemotherapy treatment

  41. Cardiac Lymphoma - TTE

  42. Cardiac Lymphoma - TEE

  43. Cardiac Lymphoma - TEE

  44. Cardiac Lymphoma – CT scan

  45. Cardiac Lymphoma - CMR

  46. Cardiac Tumor Imaging Braunwald’s 7th Edition

  47. Metastatic Disease to the Heart • Metastases can manifest in the heart as a mass, pericardial disease, myocardial involvement • Tumors can spread to heart by: direct invasion, spread through venous system or hematongenously • Cardiac involvement is often established at autopsy in patients with otherwise widely metastatic disease

  48. Metastatic Disease to the Heart

  49. Metastatic Melanoma • Metastasizes to myocardium or pericardium and involves the heart 50% of the time • Often presents as intracardiac mass • Best visualized on TTE after contrast injection • Differentiated from thrombus by intact apical wall motion

More Related